• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

特发性帕金森病中电子传递链的异常

Abnormalities of the electron transport chain in idiopathic Parkinson's disease.

作者信息

Parker W D, Boyson S J, Parks J K

机构信息

Department of Neurology, University of Colorado School of Medicine, Denver.

出版信息

Ann Neurol. 1989 Dec;26(6):719-23. doi: 10.1002/ana.410260606.

DOI:10.1002/ana.410260606
PMID:2557792
Abstract

Idiopathic Parkinson's disease may have a low-level familial association but does not follow mendelian patterns of inheritance. Since inheritance of some components of the electron transport chain is nonmendelian and since inhibition of the electron transport chain with the toxin 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine models Parkinson's disease in humans and animals, we evaluated catalytic activities of the electron transport chain in platelet mitochondria purified from patients with idiopathic Parkinson's disease. All 10 patients studied had significant reductions of complex I (NADH:ubiquinone oxidoreductase) activity. Succinate:cytochrome c oxidoreductase activity was less strikingly reduced. We hypothesize that the complex I abnormality may have an etiological role in the pathogenesis of Parkinson's disease and that this defect may be derived via the mitochondrial genome.

摘要

特发性帕金森病可能存在低度家族关联性,但并不遵循孟德尔遗传模式。由于电子传递链某些成分的遗传是非孟德尔式的,且用毒素1-甲基-4-苯基-1,2,3,6-四氢吡啶抑制电子传递链可在人和动物中模拟帕金森病,我们评估了从特发性帕金森病患者中纯化的血小板线粒体中电子传递链的催化活性。所研究的10例患者的复合体I(NADH:泛醌氧化还原酶)活性均显著降低。琥珀酸:细胞色素c氧化还原酶活性的降低则不那么明显。我们推测复合体I异常可能在帕金森病发病机制中具有病因学作用,且这种缺陷可能通过线粒体基因组遗传。

相似文献

1
Abnormalities of the electron transport chain in idiopathic Parkinson's disease.特发性帕金森病中电子传递链的异常
Ann Neurol. 1989 Dec;26(6):719-23. doi: 10.1002/ana.410260606.
2
Mitochondrial complex I, II/III, and IV activities in familial and sporadic Parkinson's disease.家族性和散发性帕金森病中线粒体复合物I、II/III和IV的活性
Int J Neurosci. 2005 Apr;115(4):479-93. doi: 10.1080/00207450590523017.
3
Neuroleptic medications inhibit complex I of the electron transport chain.抗精神病药物会抑制电子传递链的复合体I。
Ann Neurol. 1993 May;33(5):512-7. doi: 10.1002/ana.410330516.
4
Iron-dependent enzymes in Parkinson's disease.帕金森病中的铁依赖性酶。
J Neural Transm Suppl. 1995;46:157-64.
5
Immunohistochemical studies on complexes I, II, III, and IV of mitochondria in Parkinson's disease.帕金森病中线粒体复合物I、II、III和IV的免疫组织化学研究。
Ann Neurol. 1991 Oct;30(4):563-71. doi: 10.1002/ana.410300409.
6
[A case of late-onset and slowly progressive mitochondrial myopathy with abnormalities of complexes in electron-transfer system].[一例伴有电子传递系统复合体异常的迟发性、缓慢进展性线粒体肌病]
Rinsho Shinkeigaku. 1988 Oct;28(10):1147-51.
7
Complex I and Parkinson's disease.复合体I与帕金森病。
IUBMB Life. 2001 Sep-Nov;52(3-5):135-41. doi: 10.1080/15216540152845939.
8
Origin and functional consequences of the complex I defect in Parkinson's disease.帕金森病中复合物I缺陷的起源及功能后果
Ann Neurol. 1996 Oct;40(4):663-71. doi: 10.1002/ana.410400417.
9
Mitochondrial complex I deficiency in Parkinson's disease.帕金森病中的线粒体复合体I缺乏症。
J Neurochem. 1990 Mar;54(3):823-7. doi: 10.1111/j.1471-4159.1990.tb02325.x.
10
[Contribution of MPTP to studies on the pathogenesis of Parkinson's disease].[MPTP对帕金森病发病机制研究的贡献]
Rinsho Shinkeigaku. 1989 Dec;29(12):1494-6.

引用本文的文献

1
Metabolic Dysregulation in Parkinson's Disease: Non-Oxidative Phosphorylation and Its Role in Brain Energy Metabolism.帕金森病中的代谢失调:非氧化磷酸化及其在脑能量代谢中的作用
Aging Dis. 2025 Jun 22;16(5):2721-2738. doi: 10.14336/AD.2025.0619.
2
Overview of methods that determine mitochondrial function in human disease.确定人类疾病中线粒体功能的方法概述。
Metabolism. 2025 Sep;170:156300. doi: 10.1016/j.metabol.2025.156300. Epub 2025 May 17.
3
Mitochondrial dysfunction in Parkinson's disease.帕金森病中的线粒体功能障碍。
J Neural Transm (Vienna). 2024 Dec;131(12):1415-1428. doi: 10.1007/s00702-024-02863-2. Epub 2024 Nov 25.
4
Neurodegenerative disorders, metabolic icebergs, and mitohormesis.神经退行性疾病、代谢冰山和线粒体激素。
Transl Neurodegener. 2024 Sep 6;13(1):46. doi: 10.1186/s40035-024-00435-8.
5
Revisiting the Mitochondrial Function and Communication in Neurodegenerative Diseases.重新审视神经退行性疾病中的线粒体功能和通讯。
Curr Pharm Des. 2024;30(12):902-911. doi: 10.2174/0113816128286655240304070740.
6
Synaptic dysfunction and extracellular matrix dysregulation in dopaminergic neurons from sporadic and E326K-GBA1 Parkinson's disease patients.散发性和E326K-GBA1帕金森病患者多巴胺能神经元中的突触功能障碍和细胞外基质失调
NPJ Parkinsons Dis. 2024 Feb 19;10(1):38. doi: 10.1038/s41531-024-00653-x.
7
Gene Expression Profiling of Post Mortem Midbrain of Parkinson's Disease Patients and Healthy Controls.帕金森病患者和健康对照者死后中脑的基因表达谱分析。
Int J Mol Sci. 2024 Jan 5;25(2):707. doi: 10.3390/ijms25020707.
8
Clinical Trial Highlights: Modulators of Mitochondrial Function.临床试验亮点:线粒体功能调节剂
J Parkinsons Dis. 2023;13(6):851-864. doi: 10.3233/JPD-239003.
9
Transcriptome Highlights Cannabinol Modulation of Mitophagy in a Parkinson's Disease In Vitro Model.转录组亮点:大麻隆对帕金森病体外模型中线粒体自噬的调节作用。
Biomolecules. 2023 Jul 25;13(8):1163. doi: 10.3390/biom13081163.
10
Plausible Role of Mitochondrial DNA Copy Number in Neurodegeneration-a Need for Therapeutic Approach in Parkinson's Disease (PD).线粒体 DNA 拷贝数在神经退行性变中的可能作用——帕金森病 (PD) 治疗方法的需求。
Mol Neurobiol. 2023 Dec;60(12):6992-7008. doi: 10.1007/s12035-023-03500-x. Epub 2023 Jul 31.